Deborah has held executive positions as both President and Executive Vice President in Canada, the U.S., and Australia, of leading multinational pharmaceutical companies. She now serves as both a consultant to academia and the healthcare industry. Prior to this, she assumed successively more senior operational and management roles in marketing and sales, regulatory and government affairs, and research & development in the biopharma industry. She has served on both Advisory Committees and Boards of patient associations, not-for-profit organizations and life science industry associations BIOTECanada and Rx&D (now Innovative Medicines Canada) as a Board Member, Executive Committee member and Chair of the Board. Currently she is on the Strategic Executive Advisory Board for the Canadian Cancer Trials Group, and serving on the Board of Directors for the HBSPCA in addition to Life Sciences Ontario.